跳至主要内容
临床试验/CTRI/2025/09/094999
CTRI/2025/09/094999尚未招募不适用

Utility of Boger Boenninghausen’s Characteristic and Repertory in cases of Hemorrhoids using Goligher’s classification and Hemorrhoidal disease symptom score.

Dr Parth Bhatt1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Based on Hemorrhoidal disease

研究概览

简要总结

The Hemorrhoids are more pathological and main stay of treatment is surgical but in operative

Hemorrhoidectomy is usually associated with many postoperative complications like pain, bleeding, anal strictures, retention of urine, fissure, abscess etc. which can result in protracted period of convalescence. Homoeopathic medicines are extremely effective in treatment of hemorrhoids This study will emphasis on incidence, evaluation, pathophysiology, clinical feature and management of Hemorrhoids with discussion of Homoeopathic medicines indicated in this clinical condition using BBCR. Homoeopathic literature acknowledges many medicines for the Hemorrhoidal condition of which a simillimum can help a patient for keeping the disease far away for long period and offer a gentle and safe relief.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients above 18 years of age groups and both genders are eligible for the study.
  • Patients with diagnosed cases of grade 1, grade 2, grade 3 of hemorrhoids whether it is acute or chronic are eligible for study 3) Patients who are willing and are able to comply with the study protocol, including taking homeopathic treatment, attending follow-up.

排除标准

  • 4th degree Hemorrhoids will be excluded 2) Hemorrhoids with complication like infection, thrombosis, gangrene, pylephlebitis, fibrosis etc.
  • will be excluded 3) Patients who are unable or unwilling to comply with the study protocol and attending follow-up will be excluded 4) Patients below 18 years of age will be excluded.

结局指标

主要结局

Based on Hemorrhoidal disease

时间窗: At the baseline and at the end of each Follow up

symptom score

时间窗: At the baseline and at the end of each Follow up

次要结局

未报告次要终点

研究者

发起方
Dr Parth Bhatt
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Parth Bhatt

Anand Homoeopathic Medical College and Research Institute

研究点 (1)

Loading locations...

相似试验